UCB0107 (bepranemab) clinical trials

A Study to Test the Safety and Tolerability of Long-term UCB0107 Administration in Study Participants With Progressive Supranuclear Palsy

This study is looking at the long-term safety of a new medicine, UCB0107, for people with Progressive Supranuclear Palsy (PSP). It builds on a previous study to understand if the treatment is safe over a longer period.